Atherosclerosis

Pharmacological prevention of atherosclerosis and cardiovascular disease
pp. 25-25(1)
Author: Paoletti R.

The macrophage in atherogenesis: metalloproteinases and tissue factor as therapeutic targets?
pp. 25-25(1)
Author: Fuster V.

Nutritional strategies to prevent cardiovascular disease
pp. 25-25(1)
Author: Nestel P.J.

Mechanism of action of fibrates on lipid and lipoprotein metabolism
pp. 25-25(1)
Author: Fruchart J.C.

Advances in somatic gene therapy for hyperlipidemia
pp. 26-26(1)
Author: Chan L.

The impending epidemic of cardiovascular in the Asian Pacific region
pp. 26-26(1)
Authors: Asian-Pacific CHD Risk Factor Collaborative Group; Keech A.

Insulin sensitivity in growth hormone-deficient adults: effects of growth hormone replacement
pp. 26-26(1)
Author: Ho L.-T.

Pleiotropism among the statins
pp. 26-26(1)
Author: Shepherd J.

Susceptibility of low-density lipoprotein to oxidative modification in Taiwan vegetarians and omnivores
pp. 27-27(1)
Authors: Huang P.-C.; Lu S.-c.; Wu W.-H.; Yeh S.-F.

Fourteen-year follow-up study of Japanese national cardiovascular survey: Nippon Data
pp. 27-27(1)
Authors: NIPPON DATA Research Group; Ueshima H.

Ethnic differences in cardiovascular risk factors and prevalence of diabetes mellitus: the Singapore experience
pp. 27-27(1)
Author: Chee E.T.

Apolipoprotein(a) -- a new risk factor-genetic and environmental influences on phenotypic expression
pp. 27-27(1)
Author: Janus E.D.

Mechanism of the production of small, dense Ldl in hypertriglyceridemia: role of cholesteryl ester transfer protein and hepatic triglyceride lipase
pp. 28-28(1)
Author: Yamamoto A.

Cardiovascular health in women with reference to Asian women
pp. 28-28(1)
Author: Khaw K.-T.

Endothelial cell membrane and vascular matrix proteoglycans: scavenger receptors for plasma lipoproteins?
pp. 28-28(1)
Authors: Siegel G.; Malmsten M.

Nutritional pathways to coronary heart disease
pp. 28-28(1)
Author: Wahlqvist M.L.

Atherogenesis, the role of new imaging modalities and therapeutic stabilization
pp. 31-31(1)
Author: Fuster V.

Risk factor management in CHD patients in Asia: current status
pp. 31-31(1)
Authors: Asian-Pacific CHD Risk Factor Collaborative Group; Keech A.

Clopidogrel benefits over aspirin in patients with coronary disease
pp. 31-31(1)
Author: Harker L.A.

Caprie results: implications for the neurologist
pp. 31-31(1)
Author: Hankey G.J.

Peripheral arterial disease: identification and management of the high risk patient
pp. 32-32(1)
Author: Hirsch A.T.

The clinical promise of clopidogrel
pp. 32-32(1)
Author: Steg P.G.

Homocysteine: a neglected treatable cause of atherosclerosis
pp. 32-32(1)
Author: Stampfer M.

Subclinical cardiovascular disease
pp. 32-33(2)
Author: Kuller L.H.

Cardiovascular disease (CVD) risk factor status in middle-age and health care costs in older age: the Chicago heart association detection project in industry (CHA) study
pp. 33-33(1)
Authors: Kiang L.; Daviglus M.L.; Lowe L.P.; Garside D.; Greenland P.; Stamler J.

Cardiovascular disease risk in Chinese living in Taiwan and in mainland
pp. 33-33(1)
Author: Pan W.-H.

Small dense LDL: cardiovascular impact and new therapeutic approaches
pp. 33-33(1)
Authors: Chapman M.J.; Guerin M.; Bruckert E.

Modulation of the atherogenic lipoprotein phenotype with micronised fenofibrate
pp. 33-34(2)
Authors: Tan C.E.; Tai E.S.; Chio L.F.; Chew L.S.

HDL, reverse cholesterol transport and atherogenesis
pp. 34-34(1)
Author: Fruchart J.C.

Fenofibrate intervention and event lowering in diabetes: the field study
pp. 34-34(1)
Authors: Asian-Pacific CHD Risk Factor Collaborative Group; Keech A.

The effects of antioxidant from Chinese medicinal herb on intimal hyperplasia in restenosis animal model
pp. 34-34(1)
Author: Lin S.-J.

Cholesterol-lowering effect of garlic
pp. 34-34(1)
Authors: Tanphaichitr V.; Phaksang K.; Pakpeankitvatana R.; Leelahagul P.; Kraisintu K.

Looking beyond LDL-cholesterol: the emerging role of triglycerides in coronary heart disease
pp. 35-36(2)
Author: Assman G.

Mechanism for the myocardial protective effect of trilinolein
pp. 35-35(1)
Author: Hong C.-Y.

Antihyperlipidemic effect of crataegus curvisepala lind
pp. 35-35(1)
Authors: Sarrafzadegan N.; Sajadi F.; Mohammadifard N.

Bioavailability of antioxidant power in green tea
pp. 35-35(1)
Authors: Benzie I.F.F.; Szeto Y.-T.; Strain J.J.; Tomlinson B.

The clinical benefits of aggressive lipid lowering therapy
pp. 36-36(1)
Author: Farmer J.A.

Pharmacologic options for lipid disorders: the next step
pp. 36-37(2)
Author: Sy R.G.

The Asian-Pacific collaboration study on CHD risk factor intervention
pp. 37-37(1)

Prevalence and incidence of type 2 diabetes in Taiwan: impact of obesity and hyperinsulinemia
pp. 37-37(1)
Authors: Wang S.-L.; Pan W.-H.; Hwu C.-M.; Ho L.-T.

Macrovascular complications in type 2 diabetes
pp. 37-37(1)
Authors: Tai T.-Y.; Fu C.-C.; Tseng C.-H.

How should we control risk factors in patients with diabetes mellitus?
pp. 38-38(1)
Author: Ito H.

The pathological mechanisms leading to acute myocardial ischemia: stable versus unstable plaque
pp. 38-38(1)
Author: Falk E.

Coronary prevention: correlation with clinical and research data
pp. 38-38(1)
Author: Lam J.Y.T.

New event reduction analyses from the West of Scotland study
pp. 38-38(1)
Author: Shepherd J.

The long term intervention with pravastatin in ischaemic disease (LIPID) study results
pp. 39-39(1)
Authors: LIPID Study Group; Tonkin A.

Hemodynamic force-induced redox changes modulate endothelial responses
pp. 39-39(1)
Author: Ling Wang D.

Role of interleukin-12 in development of atherosclerosis in apoe-deficient mice
pp. 39-39(1)
Authors: Chau L.-Y.; Lee T.-S.; Yen H.-C.; Pan C.-C.

Applied expressed sequence tag (EST) technology to identify disease genes - focusing on vascular-cell based genes of atherosclerosis and coronary heart disease
pp. 39-39(1)
Author: Liew C.C.

LP(A) associated thrombin enhanced clot formation
pp. 40-40(1)
Authors: van Rijn H.J.M.; Kleinveld H.A.; Pekeiharing H.L.M.

Participitation of ICAM-1/LFA-1 pathway in mononuclear cell recruitment into aortic intima in hypercholesterolemic rats
pp. 40-40(1)
Authors: Qing N.; Jianglin F.; Shimokama T.; Watanabe T.

Why is blood pressure control not enough in cardiovascular disease prevention?
pp. 40-40(1)
Author: Ding P.Y.-A.

Japanese atherosclerosis society guideline for the diagnosis and treatment of hyperlipidemias in adults
pp. 40-41(2)
Author: Itakura H.

Clinical practice guidelines on the detection and management of hypercholesterolemia: the multi-sectoral task force on the detection and management of hypercholesterolemia (Philippines)
pp. 41-41(1)
Author: Ty Willing T.S.

Lipid treatment guidelines for Indians
pp. 41-41(1)
Authors: Indian Consensus Group; Singh R.

The guideline for the diagnosis and management of lipid disorders of Chinese in Taiwan
pp. 41-41(1)
Author: Ding P.Y.-A.

Beyond blood pressure reduction: target organ protection as the principal target for antihypertensive treatment
pp. 42-42(1)
Author: Elliott H.L.

Endothelial function in hypertension
pp. 42-42(1)
Author: Ding P.Y.-A.

Restoring endothelial function: the role of calcium antagonists
pp. 42-42(1)
Author: Rabelink A.J.

What could be expected from ongoing major clinical trials with calcium antagonists with respect to maintaining endothelial function
pp. 42-42(1)
Author: Noll G.

Role of dietary fats in modulating blood lipid levels
pp. 43-43(1)
Author: Khosla P.

Ethnicity, fat intake and cardioprotection
pp. 43-43(1)
Author: Wahlquist M.L.

Cardiovascular protective actions of edible oils and antioxidants
pp. 43-43(1)
Authors: Abeywardena M.Y.; Head R.J.

Beneficial effect of adlay on plasma lipids in hamsters and hyperlipidemic and diabetic patients
pp. 43-43(1)
Authors: Tsai C.E.; Lihjium Y.; Peichi S.; Chen R.M.-Y.

The hypolipidemic and antioxidative effects of pu-erh tea
pp. 44-44(1)
Authors: Lin L.-C.; Liuchang H.-C.; Hwang L.S.; Shiao M.-S.

Lipid and pleiotropic effects of statins
pp. 44-44(1)
Author: Paoletti R.

Regression of coronary atherosclerosis: LCAS proves the point
pp. 44-44(1)
Author: Deslypere J.P.

Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia
pp. 44-44(1)
Authors: Yu-An Ding P.; Huey-Herng Sheu W.; Hu C.-A.; Pei D.

A study of carotid ultrasonography in 505 cases of healthy Japanese - standard value of IMT and asymptomatic plaque
pp. 47-47(1)
Authors: Kudoh K.; Chang N.-C.

Catherization documented coronary artery disease in young Chinese adults
pp. 47-47(1)
Authors: Chu P.-H.; Chiang C.-W.; Ko L.-L.; Cheng N.-J.; Chen W.-J.; Hsu T.-S.; Lee Y.-S.

The relation between serum fibrinogen and magnesium with relative index of cpkmb / cpk activity in myocardial infarction
pp. 47-47(1)
Authors: SarrafZadegan N.; Boshtam M.; Mojtabavi M.; Iftekhari M.; Samarian H.

The changes and significance of plasma IL-6 during myocardial ischemia-reperfusion
pp. 47-47(1)
Authors: Wenhui D.; Fuxuan W.; Junhua Z.

Minimally invasive coronary artery surgery in women
pp. 48-48(1)
Authors: Pyng J.L.; Chang C.-H.; Chu J.-J.; Liu H.-P.; Tsai F.-C.; Wu Y.-C.; Chang Y.-S.

Evidence-based clinical pathways for acute myocardial infarction
pp. 48-48(1)
Authors: Lin C.-L.; Lai C.-P.; Wang J.-H.; Tseng W.-P.

Detection of atherosclerotic plaques by transesophageal echocardiography: its clinical significance and application
pp. 48-48(1)
Authors: Lin M.; Lin S.-L.; Chang M.-Y.; Tai C.-S.; Chiang H.-T.

TGF- response and restenosis after PTCA
pp. 48-48(1)
Authors: Kawaguchi A.; Yamamoto A.

Circadian urinary enothelin-1 excretion in normotensives and in patients with essential hypertension
pp. 49-49(1)
Authors: Hwang Y.-S.; Lee Y.-S.; Chen Y.-S.; Hsieh M.-C.; Tsai I.-H.

Role of advanced age and hypertension in the elderly patients =< 85 years old with hypertrophic cardiomyopathy
pp. 49-49(1)
Authors: Chang N.-C.; Lai Z.-Y.; Chan P.; Wang T.-C.

Study of coronary risk factors in an industrial population
pp. 49-49(1)
Author: Chandra S.

Enalapril upregulates smooth muscle myosin heavy chain isoform in intramyocardial arteries from spontaneously hypertensive rats
pp. 49-49(1)
Authors: Fujii K.; Umemoto S.; Fujii A.; Yonezawa T.; Matsuzaki M.

The status of major risk factors of atherosclerosis in children and adolescents of Isfahan
pp. 50-50(1)
Authors: Kelishadi R.; Hashemipoor M.

A novel mechanism by which homocyst(e)ine increases risk of premature cardiovascular disease
pp. 50-50(1)
Authors: Naruszewicz M.; Bobnis M.; Brykczynski M.; Kornacewicz-Jach Z.; Wiechowski S.

Severe renal arterial stenosis treated by balloon angioplasty in a child with hypertension
pp. 50-50(1)
Authors: Betau H.; Fu Y.-C.; Hsing H.-P.; Meng C.C.L.

In hypercholesterolemia, lower peripheral monocyte count is unique among the major predictors of atherosclerosis
pp. 50-50(1)
Authors: Huang Z.-S.; Wang C.-H.; Yip P.-K.; Yang C.-Y.; Lee T.-K.

Differential effects of growth factors on gap junction expression in cultured human aortic smooth muscle cells
pp. 51-51(1)
Authors: Yeh H.-I.; Kanthou C.; Dupont E.; Lupu F.; Severs N.J.

Demographic, hemodynamic, and biochemical determinants of intimal-medial thickness of common carotid artery
pp. 51-51(1)
Authors: Chen C.-H.; Ting C.-T.; Lin S.-J.; Hsu T.-L.; Ho S.-J.; Pesus C.; Chang M.-S.; Yin F.C.P.

Extracelluar - superoxide dismutase in coronary artery atherosclerosis
pp. 51-51(1)
Authors: Tasaki H.; Toyokawa T.; Yamashita K.; Nakashima Y.; Adachi T.

Tumor necrosis factor--mediated signaling molecules in the regulation of macrophage scavenger receptor
pp. 51-51(1)
Authors: Hsu H.-Y.; Twu Y.-C.; Chiu S.-L.; Kuo K.-L.

Age-related structural reorganization of human aortic endothelium: role in atherogenesis
pp. 52-52(1)
Authors: Iliynskaya O.; Loktionova S.; Yarovaya E.; Arefieva A.; Kalinina N.; Tararak E.

Remodeling and characteristics of the intimal proliferation of balloon injured artery: a porcine mode of restenosis
pp. 52-52(1)
Authors: Mao S.J.T.; Wu J.C.H.; Sun T.J.; Lin J.H.; Lin C.S.; Yang P.C.; Chu R.; Shyy J.Y.J.; Chien S.

Formation of MDA-lys epitope in foam cells is mediated through intracellular processing
pp. 52-52(1)
Authors: Huang G.S.; Chang W.-T.; Sun T.J.; Wang S.-C.; Chu R.; Mao S.J.T.

Hypertension inducing cerebrovascular damage and effecting on cerebral infarction
pp. 52-52(1)
Authors: Huang R.; Peng Y.

Cardiovascular disease situation and preventive actions in Iran
pp. 53-53(1)
Authors: Sarrafzadegan N.; Alikhasi H.; Abdar N.

Aggregation of cardiovascular risk factors - experience from a local community screening project in Hong Kong
pp. 53-53(1)
Authors: Chan W.K.; Chiu A.; Wu M.F.; Liu F.L.; Choi K.W.

HDl-cholesterol and triglyceride as the risk factor to myocardial infarction
pp. 53-53(1)
Author: Nakazawa K.

Association between carotid stenosis and levels of SBP, fibrinogen, blood chloride and history of kidney diseases
pp. 53-53(1)
Authors: Bai C.-H.; Chen J.-R.; Chiu H.-C.; Pan W.-H.

Incidence of hypertension in Pu-Li, Taiwan
pp. 54-54(1)
Authors: Tung T.-H.; Chen C.-H.; Pesus C.

The association of heart rate urinary electrolytes excretion in Isfahan population
pp. 54-54(1)
Authors: Rafie M.; Boshtam M.; SarrafZadegan N.; Asgary S.; Naderi G.

The difference between the relation of urinary electrolytes excretion with blood pressure in hypertensive and normotensive people in Isfahan
pp. 54-54(1)
Authors: Boshtam M.; Rafie M.; SarrafZadegan N.; Asgary S.; Naderi G.

Sex-related differences in baseline variables, therapies and outcomes in Chinese patients with acute myocardial infarction
pp. 54-54(1)
Authors: Chu P.-H.; Chiang C.-W.; Ko Y.-L.; Chang C.-J.; Cheng N.-J.; Chen W.-J.; Kuo C.-T.; Hsu T.-S.; Lee Y.-S.

Is low dose simvastatin effective to lower cholesterol in coronary patients?
pp. 55-55(1)
Authors: Leung A.W.-S.; Lo L.Y.-l.; Chan S.W.-C.; Au Y.-F.; Lau S.-T.

Effect of simvastatin and fenofibrate on hypercholesterolemia in postmenopausal women
pp. 55-55(1)
Authors: Jeng C.-Y.; Ding P.Y.-A.

Effects of fluvastatin on prothrombotic and fibrinolytic factors in non-insulin-dependent diabetic patients with dyslipidaemia
pp. 55-55(1)
Authors: Tan K.C.B.; Janus E.D.; Lam K.S.L.

Response to bezafibrate in combined hyperlipidaemia
pp. 55-55(1)
Authors: Wei L.; Tomlinson B.; Chau Y.-M.; Say T.-K.; Lee K.K.-C.; Critchley J.A.J.H.; Mak T.W.-L.; Lam C.W.-K.

Effect of synthetic HMG-COA reductase inhibitors on cholesterol synthesis in various human cell types and on progesterone secretion from human granulosa cells in culture
pp. 56-56(1)
Authors: Cohen L.H.; van Leeuwen R.E.W.; van Thiel G.C.F.

Combination treatment with fluvastatin and gemfibrozil in resistant hyperlipidaemia
pp. 56-56(1)
Authors: Tomlinson B.; Wong S.-Y.; Wei L.; Critchley J.A.J.H.; Mak T.W.-L.; Lam C.W.-K.; Woo K.S.; Sanderson J.B.

Long-term effect of a HMG-CoA reductase inhibitor, pravastatin, in glomerulonephritis patients with hyperlipidaemia: an 18-month experience
pp. 56-56(1)
Authors: Liou H.-H.; Liu M.-C.

CCS-1: effects of captopril on the early mortality and complications in 14962 patients with acute myocardial infarction
pp. 56-56(1)
Authors: Chinese Cardiac Study-I CCS-1 Collaborative group; Liu L.; Wang W.; Tao S.

Endothelial cells subjected to mechanical strain increase heme oxygenase-1 (HO-1) expression
pp. 57-57(1)
Authors: Cheng J.J.; Wung B.S.; Wang D.L.

Reactive oxygen species are involved in shear stress-induced intracellular adhesion molecule-1 (ICAM-1) expression in endothelial cells
pp. 57-57(1)
Authors: Chiu J.J.; Wung B.S.; Hsieh H.J.; Wang D.L.

Red wine inhibits neointimal hyperplasia following balloon injury in cholesterol-fed rabbits
pp. 57-57(1)
Authors: Feng A.-N.; Chen Y.-L.; Chen Y.-T.; Lin S.-J.

Nitric oxide induces cell cycle arrest and apoptosis in cultured rat vascular smooth muscle cells
pp. 57-57(1)
Authors: Chae I.H.; Kim H.S.; Park S.J.; Sohn D.W.; Oh B.H.; Lee M.M.; Park Y.B.; Choi Y.S.; Lee Y.W.

A prospective hospital-based study of acute stroke in Asia: preliminary results
pp. 58-58(1)
Authors: Asian Acute Stroke Advisory Panel Epidemiology Study Group; Wong K.S.

Serum triglycerides and apo-lipoprotein b: a ratio as sensitive predictor for premature coronary artery disease in population with desirable levels of serum cholesterol
pp. 58-58(1)
Authors: Tiwari A.; Khan S.H.; Singh A.P.; Baig H.A.; Raju B.S.

Local interaction of human aortic polymorphous endothelium with blood leukocytes: role in atherogenesis
pp. 58-58(1)
Authors: Tararak E.; Iliynskaya O.; Loktionova S.; Kalinina N.

Endothelial heterogeneity, viral infection and human atherosclerosis
pp. 58-58(1)
Authors: Smirnov V.; Romanov Y.; Bystrevskaya V.; Iliynskaya O.

Familial hypercholesterolaemia in Hong Kong
pp. 59-59(1)
Authors: Tomlinson B.; Wei L.; Mak Y.-T.; Chan Y.-S.; Mak T.W.-L.; Critchley J.A.J.H.; Maserei J.R.L.; Pang C.-P.

Effect of positive family history of atherosclerosis in modifying lipid profiles after a cardiac rehabilitation period
pp. 59-59(1)
Authors: Mohammadifard N.; Sajadi F.; Sarrafzadegan N.; Abdar N.

Homocysteine stimulates the production of cholesterol in hepatic cells
pp. 59-59(1)
Authors: Karmin O.; Lynn E.G.; Chung Y.H.; Siow Y.L.; Man R.Y.K.; Choy P.C.

Effect of dietary fish oil on plasma lipoprotein cholesterol in rats fed a diet enriched in cholesterol and sucrose
pp. 59-59(1)
Authors: Chiang M.T.; Tsai M.L.

Macrophage scavenger receptor-mediated signal transduction
pp. 60-60(1)
Authors: Hsu H.-Y.; Chiu S.-L.; Twu Y.-C.; Kuo K.-L.

Biochemical characterization of an unknown apolipoprotein and its implications for dyslipidemia and lipid peroxidation
pp. 60-60(1)
Authors: Lin K.-Y.; Yang D.-L.; Huang K.-T.; Chiang A.-N.

Effect of antioxidant in endothelial cells exposed to oxidized low-density lipoproteins
pp. 60-60(1)
Authors: Chen T.-H.; Tseng H.-P.; Yang J.-Y.; Mao S.J.T.

Plasma apolipoprotein(a) levels and phenotypes in coronary artery disease and stroke
pp. 60-60(1)
Authors: Pang R.W.C.; Janus E.D.; Lau C.P.; Yu Y.L.

Plasma levels of vitamins, antioxidants and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan
pp. 61-61(1)
Authors: Hu M.-L.; Chang C.-Y.; Lai Y.-C.; Cheng T.-J.; Lau M.-T.

Hypercholesterolaemic and atherogenic potential of foods and diet consumed by Isfahan population
pp. 61-61(1)
Authors: Rafie M.; Boshtam M.; SarrafZadegan N.; Asgary S.; Naderi G.

Can antioxidant vitamin supplementation lower risk of coronary heart disease?
pp. 61-61(1)
Authors: Benzie I.F.F.; Strain J.J.

The antioxidative capacity of black bean extract
pp. 61-61(1)
Authors: Chao P.-Y.; Tai W.-C.; Wang S.-P.; Hu S.-P.

Effect of -tocopherol on lipoxygenase-catalyze oxidation of highly unsaturated fatty acids and blood viscosity
pp. 62-62(1)
Authors: Pan B.S.; Hsu H.-H.; Chen S.; Chen H.-M.

Consumption of fruits and vegetables and blood pressure
pp. 62-62(1)
Authors: Asgary S.; SarrafZadegan N.; Naderi G.; Mohammady N.; Boshtam M.

Assessment of plasma lipids status of long-term vegetarian
pp. 62-62(1)
Authors: Peng C.-J.; Su P.-C.

The impact of macro and micronutrients daily intake on blood pressure
pp. 62-62(1)
Authors: Rafie M.; Boshtam M.; SarrafZadegan N.; Abdar N.; Sedigheh K.; Asgary S.; Naderi G.

Effect of trilinolein on superoxide dismutase activity in isolated rat cardiomyocytes subjected to hypoxia and normoxic perfusion
pp. 63-63(1)
Authors: Liu J.-C.; Chan P.; Cheng J.-T.

Bone marrow response to hypercholesterolemia (HCL) in coronary patients
pp. 63-63(1)
Authors: Smimov V.N.; Soboleva E.L.; Rogova E.M.; Akchurin R.S.; Chazov E.I.

Dominant role of low density lipoprotein receptor (LDLR) pathway for -VLDL uptake in mouse peritoneal macrophages: a study using lipoproteins and macrophages from LDLR and apolipoprotein E knockout mice
pp. 63-63(1)
Authors: Perrey S.; Ishibashi S.; Yazaki Y.; Yamada N.

Myocardial protective effect of trilinolein: a triacylglycerol isolated from the medicinal plant panax pseudoginseng
pp. 63-63(1)
Authors: Chan P.; Cheng J.-T.; Hong C.-Y.

The influence of probucol on PDGF-A and PDGF-B gene expression in peropheral blood monocytes (PBM) in patients after myocardial infraction
pp. 64-64(1)
Authors: Naruszewicz M.; Bobnis M.; Ciechanowicz A.

Effects of angiotensin receptor antagonist on ventricular remodeling and cardiac function in rat hearts with myocardial infarction
pp. 64-64(1)
Authors: Guo Z.; Hu A.

Immunolocalization of high-density lipoproteins in arterial walls of rats
pp. 64-64(1)
Authors: Vie C.Y.; Chou W.-T.; Lee T.-Y.; Kao C.-H.

The changes and significance of plasma IL-8 during myocardial ischemia-reperfusion
pp. 64-64(1)
Authors: Wenhui D.; Fuxuan W.; Junhua Z.

Effect of degree of obesity on coronary artery disease and its major risk factors
pp. 65-65(1)
Authors: Tiwari A.; Khan S.H.; Singh A.P.; Baig H.A.; Raju B.S.

Obesity ascertained by anthropometry and bioelectrical impedance analysis: correlation with coronary artery disease risk factors in a Chinese population
pp. 65-65(1)
Authors: Tai E.S.; Su C.H.; Chee E.T.

Effects of very-low calorie diet (VLCD) on the level of sagittal abdominal diameter (SAD) and lipid parameters in extremely obese women
pp. 65-65(1)
Authors: Stokic E.; Stokic A.; Ivkovic-Lazar T.; Lepsanovic L.

The prevalence of diabetes mellitus based on different diagnostic criteria in an urban community in Istafan/Iran
pp. 65-66(2)
Authors: MohammdiFard N.; SarrafZadegan N.; Sajadi F.; Abdar N.; Samarian H.

Inhibition of lysine residue of d2-dopamine receptors results in decrease dopaminergic and increase b-adrenergic effect
pp. 66-66(1)
Authors: Naderi G.; Asgary S.; SarrafZadegan N.; Boshtam M.; Rafie M.

The effect of flavonoids on the prevention of insulin glycosylation
pp. 66-66(1)
Authors: Asgary S.; Naderi G.; SarrafZadegan N.; Boshtam M.; Rafie M.

Troglitazone improved impaired endothelium-dependent vasodilation in non-insulin-dependent diabetes mellitus
pp. 66-66(1)
Authors: Suzukawa M.; Ito T.; Ayaori M.; Hisada T.; Yonemura A.; Nakajima K.; Yamashita T.; Nishiwaki M.; Ishikawa T.; Nakamura H.

Influence of current- and long-term metabolic state on PTCA-outcome in diabetics
pp. 66-67(2)
Authors: Dahm J.B.; Feldrappe A.; Niederst N.; Kuon E.; Motz W.

Constitutive signaling by the TGF type i receptor arrests cardiac looping morphogenesis
pp. 67-67(1)
Authors: Charng M.-J.; Frenkel P.A.; Schneider M.D.

Investigation of mutations and polymorphisms in the lipoprotein lipase gene
pp. 67-67(1)
Authors: Chan Y.-S.; Tomlinson B.; Mak Y.-T.; Mak T.W.-L.; Pang C.-P.

Peripheral blood mitochondrial DNA content correlated with insulin secretion and metabolic parameters during glucose clamp studies
pp. 67-67(1)
Authors: Lee H.K.; Song J.H.; Lee K.U.; Choi C.S.; Park K.S.; Shin C.S.

Relations between lipoprotein lipase gene polymorphisms and insulin resistance in patients with coronary heart disease
pp. 67-67(1)
Authors: Sheu W.H.-H.; Lee W.-J.; Jeng C.-Y.; Young M.H.; Ding Y.-A.; Chen Y.-T.

Genetic causes of hyperlipidaemia in a Malaysian population and their effects on the severity of the disease
pp. 71-71(1)
Authors: Khoo K.L.; Van Acker P.; Tan H.; Deslypere J.P.

Carotid compliance in patients with coronary heart disease
pp. 71-71(1)
Authors: Chen Y.-T.; Ting C.-T.; Sheu W.H.H.; Huang D.-S.

The association between height and serum lipids
pp. 71-71(1)
Authors: Boshtam M.; Rafie M.; Sarrafzadegan N.; Asgary S.; Naderi G.

Comparisons of physical activity levels and cardiovascular endurance with selected lipid profiles among Chinese middle-aged men
pp. 71-71(1)
Authors: Wang S.-W.; Fang C.-L.

Relationship of pathologic coronary atherosclerotic lesions to serum cholesterol in young people in Isfahan/Iran
pp. 72-72(1)
Authors: Sarrafzadegan N.; Rajabi P.; Esfandiary I.; Samarian H.; Gooddosi A.

Effect of cardiac rehabilitation on lipid profile
pp. 72-72(1)
Authors: Mohammadifard N.; Abdar N.; Sajadi F.; Ebrahimi B.

Lipid abnormalities and their treatment in patients with acute myocardial infarction in Hong Kong
pp. 72-72(1)
Authors: Mok P.H.-K.; Tomlinson B.; Wei L.; Sanderson J.E.; Woo K.S.

Unusual coronary artery dissection during percutaneous transluminal coronary angioplasty: report of a case
pp. 72-72(1)
Authors: Yeih D.F.; Tseng C.D.; Huang C.H.; Hsu K.L.; Chiang F.T.; Tseng Y.Z.

Hemodynamic evaluation of VBI
pp. 73-73(1)
Authors: Lin K.-c.; Wang P.-j.; Cheng C.-s.; Tsai Z.-j.; C.H. S.-L.

Acute pancreatitis during pregnancy of a type iii hyperlipoproteinemic (apoe2/e2) subject - a case report
pp. 73-73(1)
Authors: Chuang T.-Y.; Lu S.-C.; Lin B.J.; Ouyang C.-M.; Huang P.-c.

Secondary prevention of coronary artery disease in eastern Taiwan
pp. 73-73(1)
Authors: Lin C.-L.; Lai C.-P.; Wang J.-H.; Tseng W.-P.

A new and fast method for determining glycated hemoglobin
pp. 73-73(1)
Authors: Naderi G.H.; Asgary S.; Sarafzadegan N.; Boshtam M.; Rafie M.

The effect of flavonoids on the prevention of hemoglobin glycosylation
pp. 74-74(1)
Authors: Asgary S.; Naderi G.; Sarrafzadegan N.; Boshtam M.; Rafie M.; Arefian A.

The influence of socio-economic condition and education on blood pressure
pp. 74-74(1)
Authors: Boshtam M.; Rafie M.; SarrafZadegan N.; Asgary S.; Naderi G.

Sodium chloride intake in Isfahan population
pp. 74-74(1)
Authors: Boshtam M.; Rafie M.; Sarrafzadegan N.; Naderi G.; Isfahan S.A.

Comparison of knowledge and practice of Isfahan people about the CVD risk factors
pp. 74-74(1)
Authors: Alikhasi H.; Sarrafzadegan N.

The sex-based difference in the awareness and treatment of isolated systolic hypertension in elderly people in Isfahan/Iran
pp. 75-75(1)
Authors: Sarrafzadegan N.; Boshtam M.

The difference in the impact of obesity indicators on blood pressure
pp. 75-75(1)
Authors: Sarrafzadegan N.; Mohammdifard N.

The impact of different obesity indicators on hypertension control
pp. 75-75(1)
Authors: SarrafZadegan N.; MohammdiFard N.

Oxidized low density lipoprotein (OXLDL) and lysophosphatidylcholine (lysoPC) could induce apoptosis of cultured vascular smooth muscle cells (VSMC)
pp. 76-76(1)
Authors: Hsieh C.C.; Yen M.H.; Liu H.W.; Lau Y.T.

Coronary artery disease risk factors in hypertensive people in Isfahan
pp. 76-76(1)
Authors: Bashtam M.; Sarrafzadegan N.; Rafie M.; Naderi G.; Asgary S.

The effect of supervised exercise training on physical performance and psychological behaviour after myocardial infarction
pp. 76-76(1)
Authors: Sadeghinogorani K.; Maghsoudlou S.; SarrafZadegan N.; Moshfegh M.; Boshtam M.

Monocyte count as a risk factor for coronary heart disease
pp. 76-76(1)
Authors: Sarrafzadegan N.; Mostafavi S.

The relationship between the smoking status and serum lipids
pp. 77-77(1)
Authors: Mohammadifard N.; Abdar N.; Sajadi F.

Comparing the exercise capacity by the results of exercise test in coronary patients before and after the cardiac rehabilitation
pp. 77-77(1)
Authors: Maghsoudlou S.; Moshfegh M.; Sadeghi K.

In vitro antioxidant activities of various types of chinese tea
pp. 77-77(1)
Authors: Szeto Y.-T.; Benzie I.F.F.; Tomlinson B.

Role of apoptosis in the closure of human umbilical vessel at birth and its mechanism
pp. 77-77(1)
Authors: Kim H.S.; Seo J.U.; Hwang K.K.; Chae I.H.; Oh B.H.; Lee M.M.; Park Y.B.; Chol Y.S.; Lee Y.W.

Total antioxidant power of plasma: male-female and anticoagulant related differences
pp. 78-78(1)
Authors: Chung W.-Y.; Benzie I.F.F.; Tomlinson B.

Pattern of fat and oil consumption in Isfahan, Iran
pp. 78-78(1)
Authors: Mohammadifard N.; Jalali A.; Alikhasi H.; Rafiee M.

Psychiatric disorders and their relation to cardiovascular diseases
pp. 78-78(1)
Authors: Alikhasi H.; Zafari M.

Place and significance of sagittal abdominal diameter (SAD) in detection of visceral fat tissue distribution
pp. 78-78(1)
Authors: Stokic E.; Stokic A.; Ivkovic-Lazar T.; Lepsanovic L.

Changes in lipid profile following a short term weight control program in obese subjects
pp. 79-79(1)
Authors: Yang C.-L.; Chwang L.-C.

Angiotensin I converting enzyme inhibitory peptides are derived from soybean protein
pp. 79-79(1)
Authors: Chen J.-R.; Yang S.-C.; Lin Y.-L.; Shieh M.-J.

Combined antioxidants increase antioxidative enzyme activities in male hyperlipidemic smokers
pp. 79-79(1)
Authors: Huang C.-H.; Wu S.-J.; Chao J.C.J.; Shieh M.-J.

Bioavailability, serum and liver lipids are altered when rats are fed different doses of -carotene in diets containing cholesterol and soybean oil or lard
pp. 79-79(1)
Authors: Cheng H.-H.; Guo D.-C.

The influences of garlic on growth, antioxidative effect, and lipid metabolism in hamsters
pp. 80-80(1)
Authors: Liu Y.-L.; Shieh M.-S.; Cheng H.-H.; Shieh M.-J.

Garlic presents better effect than onion on lowering plasma lipids and antioxidative function in hamsters
pp. 80-80(1)
Authors: Liu Y.-L.; Shieh M.-S.; Hsin C.; Shieh M.-J.

Immunogenic interaction of d-2 dopaminergic and b2-adrenergic receptors
pp. 80-80(1)
Authors: Naderi G.; Asgary S.; Sarrafzadegnn N.; Rafie M.; Boshtam M.

Garlic affects the lipid metabolism and antioxidative status while treated with various lipids containing diet in hamsters
pp. 80-80(1)
Authors: Lin Y.-L.; Chen J.-R.; Shieh M.-S.; Shieh M.-J.

Hemodynamic effect on the oxidant generation in cultured endothelial cells
pp. 81-81(1)
Authors: Hsieh H.-J.; Cheng C.-C.; Wu S.-T.; Chiu J.-J.; Wung B.-S.; Wang D.L.

Cardioprotective action of melatonin in myocardial ischemia/reperfusion injury in rats
pp. 81-81(1)
Authors: Yen M.-H.; Chen H.-R.

Salvia miltiorrhiza inhibits neointimal hyperplasia following balloon injury in cholesterol-fed rabbits
pp. 81-81(1)
Authors: Yang S.-P.; Chen Y.-L.; Chou L.-L.; Shiao M.-S.; Hong C.-Y.; Lin S.-J.

The effects of hypertension and quinapril treatment on nitric oxide synthase expression in rats
pp. 81-81(1)
Authors: Chou T.-C.; Yen M.-H.; Ding Y.-A.

Prevalence of coronary and renal artery stenosis in patients with extracranial cerebral artery disease
pp. 82-82(1)
Authors: Wang Y.; Ho D.S.W.; Yan W.; Chen W.H.; Chui M.; Woo C.

Prevalence of extracranial carotid and vertebral artery disease in Chinese patients with coronary artery disease
pp. 82-82(1)
Authors: Chen W.H.; Ho D.S.W.; Ho S.L.; Cheung T.F.; Cheng S.W.K.

The therapeutic effect of cardiac catheterization in patients with chronic atypical chest pain
pp. 82-82(1)
Authors: Ho D.S.W.; Chen W.H.; Chui M.; Mak K.Y.; Lee P.

Safety, efficacy and feasibility of combined coronary, cerebral, renal and iliac angiogram performed in one sitting
pp. 82-83(2)
Authors: Ho D.S.W.; Wang Y.; Chen W.R.; Chui M.; Yan W.; Woo C.

Abdominal aorta angiography: should it become a routine for patients with hypertension or renal impairment undergoing cardiac catheterisation?
pp. 83-83(1)
Authors: Yan W.; Ho D.S.W.; Chen W.H.; Wang Y.; Chui M.; Woo C.; Tam E.

Renal function following percutaneous transluminal renal angioplasty for renal artery stenosis
pp. 83-83(1)
Authors: Yan W.; Ho D.S.W.; Chen W.H.; Wang Y.; Woo C.; Tam E.

Lipid lowering and hypouricemic action of micronized fenofibrate
pp. 83-84(2)
Author: Prajitno E.

Cardiac rehabilitation exercise programme: return to work as an outcome assessment
pp. 84-84(1)
Authors: Sarrafzadegan N.; Habibi H.R.; Mirdamadi A.; Maghsodlo S.; Sadegi K.

Usefulness of hemostatic marker in predicting survival after acute myocardial infarction
pp. 84-84(1)
Authors: Li Y.-H.; Teng J.-K.; Tsai W.-C.; Tsai L.-M.; Lin L.-J.; Chen J.-H.

Endothelial dysfunction in Fabry's disease
pp. 84-84(1)
Authors: Karetova D.; Bultas J.; Jachymova M.; Jindra A.

Serum lipoproteins and metabolic control changes in various albuminuria stage of Taiwanese NIDDM patients
pp. 84-85(2)
Authors: Chen J.-F.; Sun J.H.; Chang H.Y.; Hsien S.H.; Ho C.; Lin J.D.

Changes after dynamic observation of ultrastructure cerebral infarction in renovascular hypertensive rat
pp. 85-85(1)
Authors: Fang Y.; Huang R.

Comparison of hemodynamic characteristics in stroke, tia and control patients
pp. 85-85(1)
Authors: Chen J.-R.; Chiu H.-C.; Bai C.-H.; Wen H.P.

A study of the effect of statin on the cerebrovascular atherosclerosis: regression of cerebral artery stenosis study
pp. 85-85(1)
Authors: ROCAS Study Group; Wong K.S.

Lipid disorders in transitional societies
pp. 86-86(1)
Authors: Tanphaichitr V.; Achariyanont P.; Soipet S.; Leelahagul P.; Pakpeankitvatana R.; Suwan K.